What is the role of intravenous glucagon in treating refractory anaphylaxis in a patient taking a beta‑blocker?

Role of IV Glucagon in Refractory Anaphylaxis in Patients on Beta-Blockers

Administer IV glucagon 1-5 mg over 5 minutes followed by an infusion of 5-15 μg/min titrated to clinical response when a patient on beta-blockers develops refractory anaphylaxis that fails to respond to repeated epinephrine and aggressive fluid resuscitation 1, 2, 1.

Mechanism and Rationale

Beta-blockers block β-adrenergic receptors, which directly interferes with epinephrine's ability to reverse anaphylaxis. This creates a dangerous situation where patients develop:

• Refractory hypotension despite adequate epinephrine dosing
• Persistent bradycardia when tachycardia would be expected
• Reduced response to endogenous and exogenous catecholamines

Glucagon bypasses this blockade entirely because it works through non-β-adrenergic pathways, providing inotropic (increased contractility) and chronotropic (increased heart rate) effects that are independent of β-receptors 3.

When to Use Glucagon: The Clinical Algorithm

Step 1: Recognize Refractory Anaphylaxis in Beta-Blocker Patients

Suspect this when a patient on beta-blockers (oral, parenteral, or even topical eye drops) has anaphylaxis with:

• Persistent hypotension after 2-3 doses of IM epinephrine (0.3-0.5 mg every 5-15 minutes)
• Inadequate response to aggressive IV fluid resuscitation (1-2 L normal saline boluses)
• Bradycardia or inappropriately normal heart rate despite shock

Step 2: Dosing Protocol

Adults:

• Initial bolus: 1-5 mg IV over 5 minutes 1, 2, 1
• Follow with continuous infusion: 5-15 μg/min (or 5-15 mg/min per some guidelines), titrated to blood pressure and heart rate response 2

Pediatrics:

• 20-30 μg/kg (maximum 1 mg) IV over 5 minutes 2, 3
• May repeat or follow with infusion at same weight-based rate

Step 3: Critical Precautions

• Aspiration risk: Glucagon causes nausea and vomiting—position patient appropriately and have suction ready 2
• Monitor continuously: Patients on beta-blockers may have transient increases in pulse and blood pressure when glucagon is given, which may require additional therapy in those with coronary artery disease 4
• Do not delay epinephrine: Glucagon is adjunctive therapy, not a replacement for epinephrine and fluids

Evidence Quality and Guideline Consensus

Multiple high-quality guidelines from 2005-2017 consistently recommend glucagon for this specific scenario 1, 2, 1. The 2017 ESMO guidelines 1 and the 2005 JACI practice parameters 2 all include identical recommendations. The 2010 NIAID guidelines 3 reinforce this approach with the same dosing.

Important caveat: While guideline consensus is strong, the actual evidence base consists primarily of case reports and physiologic rationale rather than randomized trials 5, 6, 7, 8. A 2021 case report demonstrated dramatic hemodynamic improvement with glucagon in adrenaline-resistant shock 5, and a 1996 case showed similar results 6. However, a 2024 review acknowledges the lack of robust evidence despite widespread recommendations 8.

Complete Management Sequence for Beta-Blocker Patients

1. First-line (same as all anaphylaxis):

   • IM epinephrine 0.3-0.5 mg (1:1000) into lateral thigh, repeat every 5-15 minutes
   • Position patient (Trendelenburg if hypotensive, sitting if respiratory distress)
   • High-flow oxygen
   • Rapid IV fluid bolus: 1-2 L normal saline at 5-10 mL/kg in first 5 minutes 1

2. Second-line adjuncts:

   • H1 antihistamine: diphenhydramine 50 mg IV
   • H2 antihistamine: ranitidine 50 mg IV (combination superior to H1 alone) 1, 2
   • Corticosteroids: methylprednisolone 1-2 mg/kg IV every 6 hours (for biphasic reactions, not acute management) 1

3. For refractory hypotension in beta-blocker patients specifically:

   • Glucagon 1-5 mg IV over 5 minutes, then infusion 1, 2, 1
   • Continue aggressive fluid resuscitation
   • Consider vasopressors if still refractory: dopamine 2-20 μg/kg/min or vasopressin 0.01-0.04 U/min 1

4. For bradycardia:

   • Atropine 600 μg IV 1

Common Pitfalls to Avoid

• Delaying glucagon: Don't wait until the patient is in extremis. If hypotension persists after 2 doses of epinephrine and adequate fluids in a beta-blocker patient, give glucagon immediately
• Inadequate fluid resuscitation: Anaphylaxis causes massive third-spacing (up to 35% of intravascular volume lost within minutes). Most patients need multiple liters 3
• Using glucagon instead of epinephrine: Glucagon is adjunctive only—never substitute it for first-line epinephrine
• Forgetting about topical beta-blockers: Eye drops (timolol for glaucoma) can cause systemic beta-blockade
• Underdosing glucagon: Use the full 1-5 mg dose, not the lower doses used for hypoglycemia

Drug Interactions to Remember

The FDA label notes that patients on beta-blockers may have transient increases in pulse and blood pressure with glucagon, requiring monitoring and potential treatment in those with coronary disease 4. Additionally, indomethacin can paradoxically cause glucagon to lose its glucose-raising ability or even cause hypoglycemia, so monitor glucose levels 4.